Journal of obstetrics and gynaecology Canada最新文献

英文中文

Three-dimensional Microscopic Images of the Cervical Polyp by Microtomography 宫颈息肉的三维显微成像。

IF 2.2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-10-01 Epub Date: 2025-08-14 DOI: 10.1016/j.jogc.2025.103072

Ana Paula Pinho Matos MD , Osvaldo Luiz Aranda MD , Alessandra Silveira Machado PhD , Heron Werner PhD , Edward Araujo Júnior PhD , Pedro Teixeira Castro PhD

引用次数: 0

Acetaminophen Use in Pregnancy and the Purported Link to Neurodevelopmental Disorders 妊娠期对乙酰氨基酚的使用及其与神经发育障碍的关联。

IF 2.2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-10-01 Epub Date: 2025-10-10 DOI: 10.1016/j.jogc.2025.103140

Graeme N. Smith MD, PhD

引用次数: 0

Characteristics, Clinical Outcomes, and Health Care Utilization of Women with Cystic Fibrosis and Their Live Newborns Delivered in the Hospital Setting 囊性纤维化妇女及其在医院分娩的新生儿的特点、临床结果和医疗保健利用

IF 2.2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-10-01 Epub Date: 2025-03-08 DOI: 10.1016/j.jogc.2025.102809

Stephanie Y. Cheng MSc , Collette Raymond PharmD , Laurie Lambert MPH, PhD , Farah Husein PharmD, MSc , Abby McFee BA , Elizabeth Tullis MD , Anne L. Stephenson MD, PhD

Objective

As survival in cystic fibrosis (CF) continue to improve, more women with CF are considering their reproductive options. However, there are limited data on pregnancy and neonatal outcomes in this population. This study aimed to describe maternal and neonatal outcomes in women with CF and the general Canadian maternal population (general population).

Methods

Data on maternal and neonatal clinical outcomes and health care utilization for in-hospital live births were retrieved from the Canadian Institute for Health Information’s Discharge Abstract Database. Mothers with CF were identified using the International Classification of Diseases, 10^th Revision, Canadian Modification code for CF. The observation period spanned from fiscal year (FY) 2006–2007 to FY 2020–2021 for mothers with CF, and FY 2019–2020 for the general population.

Results

During the 15-year observation period, 124 mothers with CF had 146 deliveries, resulting in 154 newborns. Relative to the general population, mothers with CF were younger (median age 28 vs. 31 years) and had higher rates of comorbidities, induction of labour, epidural use, assisted delivery, and use of assisted reproductive technologies, but fewer cesarean deliveries. Nearly 85% of mothers with CF delivered in a hospital that had a CF clinic; 6.8% of mothers with CF were admitted to the intensive care unit. Neonates born to mothers with CF had high rates of multiple births, preterm delivery, and jaundice, with 26.6% requiring admission to the neonatal intensive care unit.

Conclusions

While no inferential analyses were conducted, mothers with CF and their newborns may experience worse post-delivery outcomes and may require more health care resources than the general population.

囊性纤维化（CF）患者的生存率正在增加，越来越多的女性正在考虑生育选择，然而，这一人群的妊娠和新生儿结局数据有限。本研究的目的是描述CF妇女和一般加拿大产妇人群（一般人群）的产妇和新生儿结局。方法：从加拿大健康信息研究所的出院摘要数据库中检索住院活产产妇和新生儿的临床结果和医疗保健利用情况。使用CF的ICD-10-CA代码对CF母亲进行识别。CF母亲的观察期为2006-2007财年至2020-2021财年，一般人群为2019-2020财年。结果：在15年的观察期间，124名CF母亲146次分娩中有154名新生儿。相对于一般人群，CF母亲更年轻（中位年龄28岁vs. 31岁），有更多的合并症，引产，硬膜外，辅助分娩和辅助生殖技术的使用，但剖宫产较少。近85%患有CF的母亲在有CF诊所的医院分娩。6.8%的CF母亲入住重症监护病房（ICU）。CF母亲所生的新生儿多胎、早产和黄疸的发生率较高。CF母亲所生的新生儿有26.6%住进新生儿重症监护病房。结论：虽然没有进行推断分析，但CF母亲及其新生儿可能比一般人群经历更糟糕的产后结局，可能需要更多的医疗资源使用。

{"title":"Characteristics, Clinical Outcomes, and Health Care Utilization of Women with Cystic Fibrosis and Their Live Newborns Delivered in the Hospital Setting","authors":"Stephanie Y. Cheng MSc , Collette Raymond PharmD , Laurie Lambert MPH, PhD , Farah Husein PharmD, MSc , Abby McFee BA , Elizabeth Tullis MD , Anne L. Stephenson MD, PhD","doi":"10.1016/j.jogc.2025.102809","DOIUrl":"10.1016/j.jogc.2025.102809","url":null,"abstract":"<div><h3>Objective</h3><div>As survival in cystic fibrosis (CF) continue to improve, more women with CF are considering their reproductive options. However, there are limited data on pregnancy and neonatal outcomes in this population. This study aimed to describe maternal and neonatal outcomes in women with CF and the general Canadian maternal population (general population).</div></div><div><h3>Methods</h3><div>Data on maternal and neonatal clinical outcomes and health care utilization for in-hospital live births were retrieved from the Canadian Institute for Health Information’s Discharge Abstract Database. Mothers with CF were identified using the International Classification of Diseases, 10<sup>th</sup> Revision, Canadian Modification code for CF. The observation period spanned from fiscal year (FY) 2006–2007 to FY 2020–2021 for mothers with CF, and FY 2019–2020 for the general population.</div></div><div><h3>Results</h3><div>During the 15-year observation period, 124 mothers with CF had 146 deliveries, resulting in 154 newborns. Relative to the general population, mothers with CF were younger (median age 28 vs. 31 years) and had higher rates of comorbidities, induction of labour, epidural use, assisted delivery, and use of assisted reproductive technologies, but fewer cesarean deliveries. Nearly 85% of mothers with CF delivered in a hospital that had a CF clinic; 6.8% of mothers with CF were admitted to the intensive care unit. Neonates born to mothers with CF had high rates of multiple births, preterm delivery, and jaundice, with 26.6% requiring admission to the neonatal intensive care unit.</div></div><div><h3>Conclusions</h3><div>While no inferential analyses were conducted, mothers with CF and their newborns may experience worse post-delivery outcomes and may require more health care resources than the general population.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 10","pages":"Article 102809"},"PeriodicalIF":2.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143589575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Primary Umbilical Endometriosis: A rare extra-pelvic presentation 原发性脐子宫内膜异位症：罕见的盆腔外表现。

IF 2.2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-10-01 Epub Date: 2025-08-14 DOI: 10.1016/j.jogc.2025.103078

Nitu Mishra MS (Obstetrics & Gynaecology), DNB (Obstetrics & Gynaecology) , Avantika Gupta MS (Obstetrics & Gynaecology) , Hemlata Panwar MD

引用次数: 0

Viral Load Testing Practices Among Pregnant People Living With HIV on Admission From Obstetrical Triage 从产科分诊入院的艾滋病毒感染孕妇的病毒载量检测实践。

IF 2.2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-10-01 Epub Date: 2025-08-26 DOI: 10.1016/j.jogc.2025.103089

Jessica Shu Nan Li MD, MPH , Alysha Nensi MD, MSc , Mark H. Yudin MD, MSc

Objectives

Routine viral load (VL) testing is recommended for pregnant people living with HIV (PLWH) to confirm viral suppression antenatally. The exact timing of this varies in practice. To obtain an up-to-date VL immediately prior to delivery, our institution implemented a policy to test VLs for all pregnant PLWH on admission. Our objective was to characterize testing practices since implementation.

Methods

Retrospective chart review of all pregnant PLWH admitted through obstetrical triage at St. Michael’s Hospital in Toronto, Ontario from January 2013 to December 2022. Outcomes of interest included VL completion status, stratified by year and other competing admission tasks.

Results

This study identified 135 admissions. The majority had VLs ordered (61.5%) and drawn (85.9%) on admission. VL ordering improved over the latter half of the study period (44.6% vs. 82.0%, P < 0.001). More VLs were ordered among Group B Streptococcus-negative patients (71.3%) compared to positive (41.4%) (P = 0.031) and among those who received an epidural (74.2% vs. 50.7%, P = 0.020). More VLs were drawn by nurses among patients who delivered during the admission (90.9% vs. 42.9%, P < 0.001) and patients who received an epidural (93.5% vs. 79.5%, P = 0.019).

Conclusions

While the rate of ordering VLs improved over the course of the study, the rate of drawing VLs remained high throughout, indicating that nurses consistently drew the bloodwork irrespective of an actual order. VL testing improved with the introduction of pre-printed orders, and varied by Group B Streptococcus status, epidural usage, and delivery status. These findings offer opportunities to guide future clinical practices on antenatal VL testing.

目的：建议孕妇HIV感染者（PLWH）进行常规病毒载量（VL）检测，以确认产前病毒抑制。具体的时间在实践中是不同的。为了在分娩前立即获得最新的VL，我们机构实施了一项政策，对所有怀孕的PLWH在入院时进行VL测试。我们的目标是描述自实现以来的测试实践。方法：回顾性分析2013年1月至2022年12月在安大略省多伦多市圣迈克尔医院（St. Michael's Hospital）通过产科分诊入院的所有妊娠PLWH。感兴趣的结果包括VL完成状态，按年份和其他竞争入学任务分层。结果：本研究确定了135例入院患者。大多数人在入场时订购了vl(61.5%)，并抽取了vl（85.9%）。VL排序在研究后期有所改善（44.6% vs 82.0%, P < 0.001）。gbs阴性患者（71.3%）比阳性患者（41.4%）（P = 0.031）和接受硬膜外麻醉的患者（74.2%对50.7%,P = 0.020）订购了更多的vl。入院时分娩的患者（90.9% vs 42.9%, P < 0.001）和硬膜外麻醉的患者（93.5% vs 79.5%, P = 0.019），护士绘制的vl更多。结论：虽然在整个研究过程中，静脉滴注率有所提高，但抽取静脉滴注率始终保持在较高水平，这表明护士无论实际订单如何都坚持抽血。VL测试随着预先打印的订单的引入而改进，并且根据GBS状态、硬膜外使用和交付状态而变化。这些发现为指导未来产前VL检测的临床实践提供了机会。

{"title":"Viral Load Testing Practices Among Pregnant People Living With HIV on Admission From Obstetrical Triage","authors":"Jessica Shu Nan Li MD, MPH , Alysha Nensi MD, MSc , Mark H. Yudin MD, MSc","doi":"10.1016/j.jogc.2025.103089","DOIUrl":"10.1016/j.jogc.2025.103089","url":null,"abstract":"<div><h3>Objectives</h3><div>Routine viral load (VL) testing is recommended for pregnant people living with HIV (PLWH) to confirm viral suppression antenatally. The exact timing of this varies in practice. To obtain an up-to-date VL immediately prior to delivery, our institution implemented a policy to test VLs for all pregnant PLWH on admission. Our objective was to characterize testing practices since implementation.</div></div><div><h3>Methods</h3><div>Retrospective chart review of all pregnant PLWH admitted through obstetrical triage at St. Michael’s Hospital in Toronto, Ontario from January 2013 to December 2022. Outcomes of interest included VL completion status, stratified by year and other competing admission tasks.</div></div><div><h3>Results</h3><div>This study identified 135 admissions. The majority had VLs ordered (61.5%) and drawn (85.9%) on admission. VL ordering improved over the latter half of the study period (44.6% vs. 82.0%, <em>P</em> < 0.001). More VLs were ordered among Group B <em>Streptococcus</em>-negative patients (71.3%) compared to positive (41.4%) (<em>P</em> = 0.031) and among those who received an epidural (74.2% vs. 50.7%, <em>P</em> = 0.020). More VLs were drawn by nurses among patients who delivered during the admission (90.9% vs. 42.9%, <em>P</em> < 0.001) and patients who received an epidural (93.5% vs. 79.5%, <em>P</em> = 0.019).</div></div><div><h3>Conclusions</h3><div>While the rate of ordering VLs improved over the course of the study, the rate of drawing VLs remained high throughout, indicating that nurses consistently drew the bloodwork irrespective of an actual order. VL testing improved with the introduction of pre-printed orders, and varied by Group B <em>Streptococcus</em> status, epidural usage, and delivery status. These findings offer opportunities to guide future clinical practices on antenatal VL testing.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 10","pages":"Article 103089"},"PeriodicalIF":2.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144985960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

First-Line Treatment Use and Survival Outcomes for Patients With Primary Advanced or Recurrent Endometrial Cancer in Alberta, Canada 加拿大艾伯塔省原发性晚期或复发子宫内膜癌患者的一线治疗使用和生存结果

IF 2.2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-10-01 Epub Date: 2025-09-11 DOI: 10.1016/j.jogc.2025.103107

Jacob McGee MD, MSC, FRPC , Dylan E. O’Sullivan PhD , Sophia Pin MD, MSc, FRCSC , Winson Y. Cheung MD, MPH, FRPC , Justin Riemer BSC, MBiotech , Patrick C. Turnbull PhD , Diana Martins BScH, MSc

Objective

To describe first-line treatment patterns and factors impacting survival for patients with primary advanced (stage III–IV) or recurrent (A/R) endometrial cancer (EC) in Canada.

Methods

This retrospective cohort study used health administrative data for patients with primary A/R EC (2010–2020) in Alberta, Canada. Characteristics by receipt of first-line systemic therapy were compared. Factors impacting overall survival (OS) after first-line chemotherapy were evaluated using a multivariable Cox proportional hazards model.

Results

Of 1185 patients included, 817 (68.9%) received first-line systemic therapy (advanced, n = 679 of 885; recurrent, n = 138 of 300). Patients in this cohort were generally younger, with fewer comorbidities than those who did not receive first-line systemic therapy. Patients with recurrent disease who received previous chemotherapy and who had a longer time to recurrence were more likely to receive first-line systemic therapy. The median OS was 53.5 months (95% CI 37.8–80.1); the OS was shorter with older age (≥75 vs. <65 years, adjusted hazard ratio [aHR] 1.62; 95% CI 1.18–2.23) and high-grade versus low-grade histology (aHR 1.99; 95% CI 1.59–3.67). The OS was longer in patients in stage III who had surgery (aHR 0.35; 95% CI 0.24–0.51).

Conclusion

Characteristics such as age and comorbidities impacted first-line systemic therapy use in primary A/R EC. Patients who were older, with high-grade histology, stage IV without surgery, and receiving platinum monotherapy had the shortest OS. Effective treatment options are needed to prolong survival for primary A/R EC.

目的：了解加拿大原发性晚期（III-IV期）或复发性（A/R）子宫内膜癌（EC）患者的一线治疗模式和影响生存的因素。方法：本回顾性队列研究使用了加拿大阿尔伯塔省2010-2020年原发性A/R EC患者的卫生管理数据。比较接受一线全身治疗的特点。采用多变量Cox比例风险模型评估一线化疗后影响总生存期（OS）的因素。结果：纳入的1185例患者中，817例（68.9%）接受了一线全身治疗（晚期，n = 679/885；复发，n = 138/300）。该队列中的患者通常比未接受一线全身治疗的患者更年轻，合并症更少。既往接受过化疗且复发时间较长的复发性疾病患者更有可能接受一线全身治疗。中位OS为53.5个月（95%可信区间[CI]: 37.8-80.1）；年龄越大，OS越短（≥75 vs）。结论：年龄和合并症等特征影响了原发性A/R EC一线全身治疗的使用。年龄较大，组织学分级高，未手术的IV期患者，接受铂单药治疗的总生存期最短。需要有效的治疗方案来延长原发性A/R EC的生存期。

{"title":"First-Line Treatment Use and Survival Outcomes for Patients With Primary Advanced or Recurrent Endometrial Cancer in Alberta, Canada","authors":"Jacob McGee MD, MSC, FRPC , Dylan E. O’Sullivan PhD , Sophia Pin MD, MSc, FRCSC , Winson Y. Cheung MD, MPH, FRPC , Justin Riemer BSC, MBiotech , Patrick C. Turnbull PhD , Diana Martins BScH, MSc","doi":"10.1016/j.jogc.2025.103107","DOIUrl":"10.1016/j.jogc.2025.103107","url":null,"abstract":"<div><h3>Objective</h3><div>To describe first-line treatment patterns and factors impacting survival for patients with primary advanced (stage III–IV) or recurrent (A/R) endometrial cancer (EC) in Canada.</div></div><div><h3>Methods</h3><div>This retrospective cohort study used health administrative data for patients with primary A/R EC (2010–2020) in Alberta, Canada. Characteristics by receipt of first-line systemic therapy were compared. Factors impacting overall survival (OS) after first-line chemotherapy were evaluated using a multivariable Cox proportional hazards model.</div></div><div><h3>Results</h3><div>Of 1185 patients included, 817 (68.9%) received first-line systemic therapy (advanced, n = 679 of 885; recurrent, n = 138 of 300). Patients in this cohort were generally younger, with fewer comorbidities than those who did not receive first-line systemic therapy. Patients with recurrent disease who received previous chemotherapy and who had a longer time to recurrence were more likely to receive first-line systemic therapy. The median OS was 53.5 months (95% CI 37.8–80.1); the OS was shorter with older age (≥75 vs. <65 years, adjusted hazard ratio [aHR] 1.62; 95% CI 1.18–2.23) and high-grade versus low-grade histology (aHR 1.99; 95% CI 1.59–3.67). The OS was longer in patients in stage III who had surgery (aHR 0.35; 95% CI 0.24–0.51).</div></div><div><h3>Conclusion</h3><div>Characteristics such as age and comorbidities impacted first-line systemic therapy use in primary A/R EC. Patients who were older, with high-grade histology, stage IV without surgery, and receiving platinum monotherapy had the shortest OS. Effective treatment options are needed to prolong survival for primary A/R EC.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 10","pages":"Article 103107"},"PeriodicalIF":2.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145058883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Attitudes Towards Pooled Surgical Waitlists and Group Referral in Urogynecology: Higher Contemporary Acceptance Among Patients 对联合手术候补名单和泌尿妇科小组转诊的态度：当代患者接受程度较高。

IF 2.2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-10-01 Epub Date: 2025-08-14 DOI: 10.1016/j.jogc.2025.103077

Hisham Khalil MD , Sarah Kanji MD, MSc , Taraneh Tabatabaei BSc , Gurveen Cheema BSc , Aisling Clancy MD, MSc, MPH

Objectives

Consolidation of individual surgeon waitlists into a collective pool has been implemented in many public systems to optimize resource use and ensure equitable access to surgical care. Acceptance of such strategies was noted to be limited in urogynecology. We aimed to evaluate patient acceptance of pooled surgical waitlists in a contemporary population and compare results to a historical pre-COVID-19 pandemic.

Methods

This cross-sectional study surveyed patients awaiting urogynecologic surgery after signing consent from 2022 to 2023. All responses were collected anonymously. Patient attitudes toward the potential for a pooled surgical waitlist were explored. We compared survey results to data from a historical cohort of published data from 2019 (N = 176) to evaluate whether there was a change in attitudes.

Results

Of the 101 patients awaiting surgery who completed the survey, 42% (42/101) reported that they would like to be offered the option of having surgery done by the next available skilled surgeon, rather than wait for their own surgeon, and this did not differ by patient symptom severity (P = 0.52). Overall, 53% (54/101) of patients reported feeling comfortable being referred to the first available urogynecologist for both consultation and follow-up visit. More respondents agreed with the pooled surgical waitlist option than in the historical cohort (42% vs. 19%, P < 0.001).

Conclusions

There appears to be greater acceptance of pooled surgical waitlists in a contemporary analysis, potentially supporting such a strategy in future urogynecology populations.

目的：在许多公共系统中，为了优化资源利用并确保公平获得外科护理，已将个别外科医生候补名单整合为一个集体池。在泌尿妇科，对这种策略的接受程度是有限的。我们的目的是评估当代人群中患者对合并手术候补名单的接受程度，并将结果与历史上的covid-19大流行前的结果进行比较。方法：本横断面研究调查了2022-2023年签署同意后等待泌尿妇科手术的患者。所有的回答都是匿名收集的。探讨了患者对合并手术候补名单的态度。我们将调查结果与2019年发表的历史队列数据（N = 176）进行了比较，以评估态度是否发生了变化。结果：在完成调查的101名等待手术的患者中，42%（42/101）的患者报告他们希望由下一个可用的熟练外科医生进行手术，而不是等待他们自己的外科医生，这与患者症状严重程度没有差异（P = 0.52）。53%（54/101）的患者报告说，当他们被推荐给第一个可用的泌尿妇科医生进行咨询和随访时，他们感觉很舒服。与历史队列相比，更多的受访者同意合并手术等待名单选项（42%对19%，P < 0.001）。结论：在一项当代分析中，似乎更多人接受合并手术候诊名单，这可能支持未来泌尿妇科人群采用这种策略。

{"title":"Attitudes Towards Pooled Surgical Waitlists and Group Referral in Urogynecology: Higher Contemporary Acceptance Among Patients","authors":"Hisham Khalil MD , Sarah Kanji MD, MSc , Taraneh Tabatabaei BSc , Gurveen Cheema BSc , Aisling Clancy MD, MSc, MPH","doi":"10.1016/j.jogc.2025.103077","DOIUrl":"10.1016/j.jogc.2025.103077","url":null,"abstract":"<div><h3>Objectives</h3><div>Consolidation of individual surgeon waitlists into a collective pool has been implemented in many public systems to optimize resource use and ensure equitable access to surgical care. Acceptance of such strategies was noted to be limited in urogynecology. We aimed to evaluate patient acceptance of pooled surgical waitlists in a contemporary population and compare results to a historical pre-COVID-19 pandemic.</div></div><div><h3>Methods</h3><div>This cross-sectional study surveyed patients awaiting urogynecologic surgery after signing consent from 2022 to 2023. All responses were collected anonymously. Patient attitudes toward the potential for a pooled surgical waitlist were explored. We compared survey results to data from a historical cohort of published data from 2019 (N = 176) to evaluate whether there was a change in attitudes.</div></div><div><h3>Results</h3><div>Of the 101 patients awaiting surgery who completed the survey, 42% (42/101) reported that they would like to be offered the option of having surgery done by the next available skilled surgeon, rather than wait for their own surgeon, and this did not differ by patient symptom severity (<em>P</em> = 0.52). Overall, 53% (54/101) of patients reported feeling comfortable being referred to the first available urogynecologist for both consultation and follow-up visit. More respondents agreed with the pooled surgical waitlist option than in the historical cohort (42% vs. 19%, <em>P</em> < 0.001).</div></div><div><h3>Conclusions</h3><div>There appears to be greater acceptance of pooled surgical waitlists in a contemporary analysis, potentially supporting such a strategy in future urogynecology populations.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 10","pages":"Article 103077"},"PeriodicalIF":2.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144862768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Letter to the Editor: Canada’s Perinatal Mental Health Landscape: Policy, Practice, and the Path Forward 致编辑的信：加拿大的围产期心理健康状况：政策、实践和前进的道路

IF 2.2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-10-01 Epub Date: 2025-10-29 DOI: 10.1016/j.jogc.2025.103101

Leo Zhao BHS student , Sandra Halliday MSc, MLIS , Michelle Carter RM, BSc, BSN, MSN , Josephine Etowa RN, RM, PhD , Canadian Academy of Nursing Fellows Expert Panel on Perinatal Mental Health and Guests, Shahirose Sadrudin Premji RN, BSc, MScN, PhD

引用次数: 0

Content, Quality, and Reliability of Endometriosis Videos on YouTube YouTube上子宫内膜异位症视频的内容、质量和可靠性。

IF 2.2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-10-01 Epub Date: 2025-03-14 DOI: 10.1016/j.jogc.2025.102814

Alexandra McGough MD, MPH , Rebecca J. Schneyer MD , Kacey M. Hamilton MD , Gabriel Levin MD , Matthew T. Siedhoff MD, MSCR , Kelly N. Wright MD , Raanan Meyer MD

We aimed to assess the content and quality of YouTube videos about endometriosis. Apify was used to retrieve videos, and 138 videos were included. Most videos originated in high-income countries and 50.0% were monetized. Median Patient Education Materials Assessment Tool Actionability and Understandability were 95.0 and 100.0, respectively. The Median Discern score was 67.5. Compared to other sources, Patient Education Materials Assessment Tool Actionability and Discern scores were significantly higher for health care professional videos and for videos created from 2021 onward. There was a significant positive association between the videos’ year of appearance and the promotion of endometriosis awareness. In conclusion, endometriosis videos are of high quality, especially when produced by health care professionals, endometriosis awareness promotion has increased over the years.

我们的目的是评估YouTube上有关子宫内膜异位症的视频的内容和质量。使用Apify检索视频，共纳入138个视频。大多数视频来自高收入国家，50.0%的视频被货币化。PEMAT可操作性和可理解性的中位数分别为95.0和100.0。辨别得分中位数为67.5。与其他来源相比，医疗保健专业视频和2021年以后制作的视频的PEMAT可操作性和分辨力得分明显更高。视频出现的年份与促进子宫内膜异位症的意识之间存在显著的正相关。总之，子宫内膜异位症的视频质量很高，特别是由医疗保健专业人员制作的视频，多年来对子宫内膜异位症的认识不断提高。

引用次数: 0

Preeclampsia Prediction Transformed: The Promise of Arterial Stiffness 短标题（最多50个字符）：动脉硬度预测子痫前期。

IF 2.2 Q2 OBSTETRICS & GYNECOLOGY

Journal of obstetrics and gynaecology Canada

Pub Date : 2025-10-01 Epub Date: 2025-03-25 DOI: 10.1016/j.jogc.2025.102820

Brenda Valdes Sustaita PhD , Elspeth Skeats , Mekayla Forrest , Maria Matossian MSc , Helena Papacostas Quintanilla PhD , Christian Delles MD , Stella S. Daskalopoulou MD, PhD

引用次数: 0

首页上一页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Journal of obstetrics and gynaecology Canada

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀